AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19958428
Drug: Six weekly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Six weekly full‐face treatments of a pneumatically applied topical polyphenolic antioxidant solution (Group B)
Trial: 15884262
Drug: GnRH analogue
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH analogue (50 mg oral doses)
Trial: 8610901
Drug: Transnasal butorphanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transnasal butorphanol 1 mg
Trial: 8610901
Drug: Transnasal butorphanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transnasal butorphanol 2 mg
Trial: 8055737
Drug: Transnasal butorphanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transnasal butorphanol 4 mg
Trial: 8055737
Drug: Intramuscular butorphanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular butorphanol 1 mg
Trial: 8055737
Drug: Intramuscular butorphanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular butorphanol 2 mg
Trial: 8055737
Drug: Intramuscular butorphanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular butorphanol 4 mg
Trial: 3056221
Drug: Postoperative immunochemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative immunochemotherapy (streptococcus pyogenes preparation (picibanil) intramuscularly every week, plus either MFC or FME chemotherapy regimen)
Trial: 3056221
Drug: Surgery alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery alone (no further anticancer therapy)
Trial: 17244767
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral 600-mg dose of cyclosporine with a single 100-mg oral sitagliptin dose
Trial: 17244767
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral 100-mg sitagliptin dose alone
Trial: 15258553
Drug: metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metformin + pioglitazone 30 mg
Trial: 11832307
Drug: α-blockers
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: α-blockers
Trial: 2701034
Drug: Magnetic device
RxNorm normalized name: MAGNESIA
DrugBank: Magnesium oxide (DB01377)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnetic device therapy
Trial: 786669
Drug: 1.2 mg
RxNorm normalized name: RNA 1.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg methyl proscillaridin (oral administration)
Trial: 786669
Drug: 1.2 mg
RxNorm normalized name: RNA 1.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg methyl proscillaridin (intravenous administration)
Trial: 786669
Drug: 1.2 mg
RxNorm normalized name: RNA 1.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg methyl proscillaridin (oral and iv administration)
Trial: 29722166
Drug: SRP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP plus 1% ALN gel
Trial: 29722166
Drug: SRP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP plus AV gel
Trial: 21998479
Drug: Valacyclovir 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 1.5 g twice daily for 12 weeks
Trial: 21998479
Drug: Acyclovir 400
RxNorm normalized name: acyclovir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 400 mg twice daily for 12 weeks
Trial: 16927137
Drug: IV pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV pantoprazole (40 mg once daily for 7 days)
Trial: 16927137
Drug: Oral pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pantoprazole (40 mg once daily for 7 days)
Trial: 16927137
Drug: IV/oral pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV/oral pantoprazole
Trial: 15742550
Drug: Enfuvirtide (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enfuvirtide (90 mg subcutaneously twice daily) plus optimized background regimen
Trial: 9849404
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b (IFN-alpha 2b) as adjuvant therapy
Trial: 10319136
Drug: Formulation A
RxNorm normalized name: meningococcal vaccine of unknown formulation and unknown serogroups
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation A (0.5 mg oral digoxin)
Trial: 10319136
Drug: Formulation B
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation B (0.5 mg oral digoxin)
Trial: 10319136
Drug: Formulation C
RxNorm normalized name: Army Liposome Formulation component monophosphoryl lipid A
DrugBank: Monophosphoryl lipid A (DB19290)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation C (0.5 mg oral digoxin, standard)
Trial: 2687956
Drug: Thoracic radiation
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic radiation with chemotherapy
Trial: 2687956
Drug: Combined modality
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined modality treatment after resection of rectal cancer
Trial: 2687956
Drug: Radiation and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation and concurrent 5-fluorouracil for squamous cancers of the anal canal
Trial: 53659
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 1‐25 megaunits of penicillin
Trial: 53659
Drug: Local wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local wound irrigation with 100mg of tetracycline in solution
Trial: 30714820
Drug: Single extended
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single extended release (ER) methylphenidate dose
Trial: 29087804
Drug: Extraction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extraction treatment
Trial: 29087804
Drug: Air-rotor stripping
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air-rotor stripping (ARS) treatment
Trial: 29087804
Drug: Non-extraction treatment
RxNorm normalized name: Hyacinthoides non-scripta extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-extraction treatment
Trial: 25373438
Drug: Prophylactic dose
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic dose low-molecular-weight heparin (LMWH) for 21 days
Trial: 25373438
Drug: Saline placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline placebo injections for 21 days
Trial: 23874588
Drug: Soy isoflavone
RxNorm normalized name: soy isoflavone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy isoflavone capsules (80 mg/d total isoflavones, 51 mg/d aglucon units)
Trial: 21334240
Drug: Lidocaine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (50 mg Xilonibsa 10% before examination)
Trial: 17109339
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A treatment for 2 weeks
Trial: 17109339
Drug: Standardized antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized antiretroviral therapy (ART)
Trial: 11239186
Drug: NXY-059 (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NXY-059 (250 mg over 1 hour followed by 85 mg/h for 71 hours)
Trial: 11239186
Drug: NXY-059 (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NXY-059 (500 mg over 1 hour followed by 170 mg/h for 71 hours)
Trial: 9227720
Drug: Inhaled formoterol
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled formoterol 24 micrograms twice daily
Trial: 27632893
Drug: Preladenant 2
RxNorm normalized name: Preladenant
DrugBank: Preladenant (DB11864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preladenant 2 mg BID
Trial: 27632893
Drug: Preladenant 5
RxNorm normalized name: Preladenant
DrugBank: Preladenant (DB11864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preladenant 5 mg BID
Trial: 27632893
Drug: Preladenant 10
RxNorm normalized name: Preladenant
DrugBank: Preladenant (DB11864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preladenant 10 mg BID
Trial: 18849079
Drug: Sertraline (or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (or amitriptyline as a second choice) plus Interpersonal Psychotherapy modified for inpatients (IPT)
Trial: 18849079
Drug: Sertraline (or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (or amitriptyline as a second choice) plus Clinical Management (CM)
Trial: 12487221
Drug: DPI (Dry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DPI (Dry Powder Inhaler) - 200 microg of inhaled budesonide twice daily for 1 month
Trial: 12487221
Drug: pMDI +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pMDI + spacer (Pressurized Metered-Dose Inhaler with spacer) - 200 microg of inhaled budesonide twice daily for 1 month
Trial: 2560799
Drug: Hormones plus
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormones plus plasmapheresis
Trial: 2560799
Drug: Hormones alone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormones alone
Trial: 30666071
Drug: Intralesional MMR
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional MMR vaccine
Trial: 31650487
Drug: Phyllanthus amarus
RxNorm normalized name: Phyllanthus amarus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phyllanthus amarus (PP) by nanoparticle gel phonophoresis
Trial: 25933498
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of L-glutamine (GLN) daily for 14 days
Trial: 25933498
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of L-alanine (ALA) daily for 14 days
Trial: 22378476
Drug: Modified Forced-Use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Forced-Use Therapy (mFUT)
Trial: 19763135
Drug: EPA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA treatment (1.8 g administered daily for 3 months)
Trial: 16087985
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (10 mg Zn as sulfate daily)
Trial: 16087985
Drug: Stimulation alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulation alone (weekly home visits for play demonstration and maternal-child interaction encouragement)
Trial: 8673545
Drug: L-697,661 as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-697,661 as monotherapy
Trial: 8673545
Drug: L-697,661 administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-697,661 administered concomitantly with zidovudine (ZDV)
Trial: 6749427
Drug: Cholestyramine (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine (24 g daily) and diet
Trial: 29407226
Drug: Physical Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical Therapy Exercise
Trial: 25589511
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate plus glucosamine hydrochloride (CS+GH) 400 mg CS plus 500 mg GH three times a day for 6 months
Trial: 30648524
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg daily for 6 months
Trial: 22535977
Drug: Insulin withdrawal
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin withdrawal after 16 hours of hyperglycemia
Trial: 22535977
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion after 16 hours of euglycemia
Trial: 20309389
Drug: Percutaneous adhesiolysis
RxNorm normalized name: PERCUTANEOUS INTRODUCER SET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous adhesiolysis with target delivery of lidocaine, 10% hypertonic sodium chloride solution, and non-participate betamethasone.
Trial: 20309389
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural steroid injections with catheterization up to S3 with local anesthetic, steroids, and 0.9% sodium chloride solution.
Trial: 15961678
Drug: PUFA-supplemented liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUFA-supplemented liquid oral diet (3.7 g of PUFA, 1000 mL/d for 5 days preoperatively)
Trial: 12616980
Drug: Monophasic oral
RxNorm normalized name: hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Urelle]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monophasic oral contraceptive containing 75 micrograms of gestodene and 20 micrograms of ethinyl estradiol
Trial: 12616980
Drug: Both oral
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both oral contraceptives
Trial: 7500751
Drug: Desogestrel-containing oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel-containing oral contraceptive
Trial: 12616980
Drug: Gestodene-containing oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestodene-containing oral contraceptive
Trial: 10361867
Drug: 15 mg/d
RxNorm normalized name: Valtoco, 15 mg/dose nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/d of folic acid and 200 mg/d of pyridoxine for 4 wk
Trial: 7627722
Drug: Protein-bound polysaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-bound polysaccharide P (PSK) therapy
Trial: 7627722
Drug: PSK therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSK therapy in patients with abnormal levels of alpha 1-antichymotrypsin and sialic acid
Trial: 2021332
Drug: Sulfate free‐electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfate free‐electrolyte lavage solution
Trial: 3095080
Drug: Polyethylene glycol
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol electrolyte lavage solution
Trial: 25283485
Drug: MS+G (metformin-sitagliptin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MS+G (metformin-sitagliptin + glargine)
Trial: 25283485
Drug: MG+S (metformin-glargine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MG+S (metformin-glargine + sitagliptin)
Trial: 25283485
Drug: MS+G and
RxNorm normalized name: MS-1819
DrugBank: MS-1819 (DB15004)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MS+G and MG+S
Trial: 23695420
Drug: Raloxifene (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (daily for 2 years)
Trial: 19013526
Drug: 25OHD (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25OHD (25 microg/day) administration for 2 weeks
Trial: 8179541
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (4-g bolus intravenously)
Trial: 2820359
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy (alternate-month outpatient)
Trial: 2820359
Drug: Inpatient induction
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient induction therapy
Trial: 2820359
Drug: Outpatient induction
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient induction therapy
Trial: 3323596
Drug: Cyclophosphamide treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide treatment
Trial: 22224243
Drug: Neuromidin as
RxNorm normalized name: Neurokinin p
DrugBank: Substance P (DB19198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromidin as an add-on to basic treatment
Trial: 22224243
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment (antiaggregant, antihypertensive, cardiac and antidiabetic drugs)
Trial: 15053297
Drug: Zinc containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc containing infusion
Trial: 15053297
Drug: No zinc
RxNorm normalized name: ZINC OXIDE 140 mg in 1 mL TOPICAL CREAM [Lucin Organics Tinted Sunscreen SPF 30 Non Nano Zinc Oxide]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No zinc containing infusion (Control)
Trial: 10835438
Drug: Nalmefene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalmefene (60 mg administered as a 10 mg bolus over 15 minutes and then a 50 mg infusion over 23.75 hours)
Trial: 7901056
Drug: Intravaginal 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal 2.0 mg prostaglandin E2 gel
Trial: 7901056
Drug: Intravaginal 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal 3.0 mg prostaglandin E2 gel
Trial: 3536232
Drug: Calcitriol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol (1 microgram daily)
Trial: 28299514
Drug: CXCR4 peptide
RxNorm normalized name: Peptide T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CXCR4 peptide antagonist LY2510924 plus carboplatin-etoposide (CE)
Trial: 21282537
Drug: Vandetanib 100
RxNorm normalized name: vandetanib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vandetanib 100 mg/d plus pemetrexed 500 mg/m² every 21 days
Trial: 16859122
Drug: Chemoembolization of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoembolization of bilateral internal iliac arteries with anticancer agents and gelatin sponge particles during Miles operation
Trial: 11233804
Drug: Meropenem 1
RxNorm normalized name: meropenem 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 1 g i.v. every 8 hours
Trial: 11233804
Drug: Ceftazidime 2
RxNorm normalized name: ceftazidime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 2 g i.v. every 8 hours plus Amikacin 15 mg/kg daily
Trial: 8039271
Drug: Flumazenil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.5 mg, i.v. bolus)
Trial: 25081818
Drug: Problem Solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem Solving Therapy (PST)
Trial: 25615523
Drug: Evidence-based anxiety
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based anxiety intervention (including cognitive behavioral therapy and medications)
Trial: 16506042
Drug: Multidisciplinary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary treatment (psychological and physical sessions)
Trial: 12486426
Drug: Lisinopril treatment
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril treatment for 6 weeks
Trial: 16091636
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no lisinopril)
Trial: 1416011
Drug: 0.12 mg
RxNorm normalized name: iodine 0.12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12 mg Cl (group B)
Trial: 1416011
Drug: 0.24 mg
RxNorm normalized name: vitamin A 0.24 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.24 mg Cl (group C)
Trial: 2860687
Drug: Nonabine (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonabine (5, 10, and 15 mg)
Trial: 2860687
Drug: Ketazolam (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketazolam (30 and 45 mg)
Trial: 20354459
Drug: Allovectin-7 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allovectin-7 (2 mg, high dose)
Trial: 14668075
Drug: bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: bupropion SR (150 or 300 mg) and behavioral counseling (tailored mailings or proactive telephone counseling)
Trial: 14668075
Drug: bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: bupropion SR (lower dose)
Trial: 10780310
Drug: Bemiparin (3,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bemiparin (3,500 anti-Xa IU daily)
Trial: 10780310
Drug: UFH (5,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH (5,000 IU twice daily)
Trial: 1521812
Drug: Dexamethasone 0.1%
RxNorm normalized name: DEXAMETHASONE 0.1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.1% eye drops, 5 times daily for 5 days
Trial: 1521812
Drug: Prednisolone acetate
RxNorm normalized name: Prednisolone Acetate
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone acetate 1.0% eye drops, 5 times daily for 5 days
Trial: 29889310
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with epilepsy (before treatment)
Trial: 29889310
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with epilepsy (after treatment)
Trial: 21030704
Drug: Conventional temperature
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional temperature management (stepwise fever management with antiinflammatory drugs and surface cooling)
Trial: 21030704
Drug: Nonsteroidal antiinflammatory
RxNorm normalized name: Arthriten Inflammatory Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal antiinflammatory drugs (used as additional treatment of fever)